A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH
- 23 January 2009
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 1250, 130-140
- https://doi.org/10.1016/j.brainres.2008.11.006
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Imbalance of Angiotensin Type 1 Receptor and Angiotensin II Type 2 Receptor in the Rostral Ventrolateral MedullaHypertension, 2008
- Angiotensin II AT1receptor blockade selectively enhances brain AT2receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive ratsStress, 2008
- Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARγEuropean Journal of Pharmacology, 2006
- AT 1 Receptor Blockade Regulates the Local Angiotensin II System in Cerebral Microvessels From Spontaneously Hypertensive RatsStroke, 2006
- A Centrally Acting, Anxiolytic Angiotensin II AT1 Receptor Antagonist Prevents the Isolation Stress-Induced Decrease in Cortical CRF1 Receptor and Benzodiazepine BindingNeuropsychopharmacology, 2005
- Brain Angiotensin II: New Developments, Unanswered Questions and Therapeutic OpportunitiesCellular and Molecular Neurobiology, 2005
- Angiotensin AT2 receptor protects against cerebral ischemia‐induced neuronal injuryThe FASEB Journal, 2005
- Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.JCI Insight, 1996
- AT1A, AT1B, and AT2angiotensin II receptor subtype gene expression in rat brainNeuroReport, 1995
- The use of 14C-labeled tissue paste standards for the calibration of 125I-labeled ligands in quantitative autoradiographyNeuroscience Letters, 1987